Pnc Financial Services Group, Inc. Nex Immune, Inc. Transaction History

Pnc Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.3 - $0.6 $44,580 - $89,161	148,602 Added 88.75%	316,039 $120,000
Q4 2022 Feb 10, 2023	BUY	$0.21 - $18.5 $11,666 - $1.03 Million	55,555 Added 49.65%	167,437 $40,000
Q1 2022 May 12, 2022	BUY	$1.79 - $4.65 $170,236 - $442,233	95,104 Added 566.84%	111,882 $471,000
Q4 2021 Feb 11, 2022	BUY	$4.11 - $15.13 $68,957 - $253,851	16,778 New	16,778 $77,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.25M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.